Key facts
- QuickTake Health’s last known valuation is $5.7M (Sep 2025).
- It has raised $1.9M; the latest was Seed Round ($1.8M) in Sep 2025.
- Notable investors include Fuel Accelerator, LG Nova.
- QuickTake Health has filed 1 Form D with the SEC, most recently Dec 2022 ($220K sold to 6 investors).
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for QuickTake Health
- ·The full record, as it builds
Funding rounds
No funding rounds for QuickTake Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About QuickTake Health
Developer of vital signs workflow automation platform designed to increase documentation accuracy and reduce human error. The company's platform uses biometric sensors and speech recognition to target medical clinics, med spas, health clubs and senior living communities, enabling clinicians to focus on the patient and creating a safer, quicker measurement experience for the patient.
- Sector
- Healthcare
- HQ
- New Orleans, LA, United States
- Founded
- 2021
- Employees
- 3
- Website
- quicktakehealth.com/
- Ownership
- Privately Held (backing)
QuickTake Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in QuickTake Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on QuickTake Health in its N-PORT filings yet. We sweep new filings monthly.